The Effect of Polyphenols on Protein Degradation Pathways: Implications for Neuroprotection

Parvana Hajieva1

  • 1Department of Pathobiochemistry, University Medical Center of the Johannes Gutenberg University, Duesbergweg 6, 55099 Mainz, Germany. hajieva@uni-mainz.de.

Insights

Polyphenols show promise in combating neurodegenerative diseases by stabilizing protein degradation pathways. These compounds can help prevent the buildup of harmful oxidized and misfolded proteins.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Neurodegenerative diseases are linked to the accumulation of oxidized, aggregated proteins.
  • Cellular protein quality control failure contributes to misfolded protein buildup.
  • Polyphenols are being investigated for their therapeutic potential against protein aggregation.

Purpose of the Study:

  • To review the scientific literature on polyphenol effects on major protein degradation pathways.
  • To evaluate polyphenols as a strategy to prevent misfolded protein accumulation in neurodegeneration.

Main Methods:

  • Literature review of studies on polyphenols and protein degradation.
  • Analysis of effects on chaperone-mediated autophagy, the proteasome, and macroautophagy.

Main Results:

  • Polyphenolic compounds influence protein degradation pathways.
  • These compounds can modulate chaperone-mediated autophagy, proteasomal activity, and macroautophagy.
  • Polyphenols offer a potential therapeutic strategy for neurodegenerative proteinopathies.

Conclusions:

  • Polyphenols can positively impact protein quality control mechanisms.
  • Targeting protein degradation pathways with polyphenols is a promising therapeutic avenue for neurodegenerative diseases.
  • Further research into polyphenol mechanisms is warranted.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.9K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.1K
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
54.4K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K